PolyNovo Limited (ASX: PNV)

Australia flag Australia · Delayed Price · Currency is AUD
1.950
-0.060 (-2.99%)
Dec 20, 2024, 4:10 PM AEST
18.18%
Market Cap 1.35B
Revenue (ttm) 103.23M
Net Income (ttm) 5.26M
Shares Out 690.76M
EPS (ttm) 0.01
PE Ratio 260.00
Forward PE 142.02
Dividend n/a
Ex-Dividend Date n/a
Volume 1,600,830
Open 2.000
Previous Close 2.010
Day's Range 1.942 - 2.020
52-Week Range 1.475 - 2.780
Beta 1.67
Analysts n/a
Price Target n/a
Earnings Date Nov 27, 2024

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MT... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 254
Stock Exchange Australian Securities Exchange
Ticker Symbol PNV
Full Company Profile

Financial Performance

Financial Statements

News

Polynovo Ltd (CALZF) (Q4 2024) Earnings Call Transcript Highlights: Record Revenue and ...

Polynovo Ltd (CALZF) (Q4 2024) Earnings Call Transcript Highlights: Record Revenue and Strategic Growth

4 months ago - GuruFocus